查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571826

瘧疾診斷市場規模、佔有率、趨勢分析報告：按技術、最終用途、地區、細分市場預測，2024-2030 年

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic Tests), By End Use (Clinics, Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

瘧疾診斷市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，2024 年至 2030 年，全球瘧疾診斷市場規模預計將以 2.6% 的複合年成長率成長，到 2030 年將達到 9.005 億美元。

流行國家熱帶疾病盛行率的增加、新型診斷技術的市場開拓以及地區政府和私人投資者投資的增加預計將推動市場成長。瘧疾是最普遍、威脅生命的疾病，由於氣候變遷、經濟成長緩慢、醫療基礎設施不發達以及缺乏先進治療方法，常見於熱帶和亞熱帶地區。

政府措施和市場參與企業增加的投資預計也將在不久的將來推動市場成長。在 COVID-19 大流行期間，非洲地區可用的抗瘧治療方案非常豐富，可用於控制和遏制感染的傳播。在 COVID-19 大流行期間，除了 COVID-19 病毒外，瘧疾病例持續增加，市場受到重大提振。

大公司正在實施許多消滅瘧疾計劃，以遏止這種疾病的傳播。例如，諾華公司的瘧疾計畫旨在加速消除和控制瘧疾。該公司與各種組織一起為 60 個國家的 7.5 億人提供了非營利性護理。希望這些努力能鼓勵新技術的開拓並有助於市場滲透。

瘧疾診斷市場報告亮點

  • 顯微鏡傳統上用於檢測瘧疾原蟲，是顯微鏡技術領域的領導者。
  • 由於易於使用、方便和快速診斷，RDT 預計將佔據最大的銷售佔有率。
  • 由於其準確性和檢測低寄生蟲數量的能力，分子診斷測試領域預計將成為預測期內成長最快的技術領域。
  • 由於瘧疾盛行率高以及各種瘧疾診斷技術的採用不斷增加，非洲將在 2023 年引領市場。
  • 由於疾病頻繁復發以及遏制瘧疾流行的努力，東南亞預計將以 2.3% 的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章瘧疾診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 瘧疾診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章瘧疾診斷市場：技術評估與趨勢分析

  • 技術市場佔有率，2023/2030
  • 細分儀表板
  • 全球瘧疾診斷市場：按技術展望
  • 2018-2030年市場規模/預測與趨勢分析

第5章瘧疾診斷市場：最終用途估計與趨勢分析

  • 2023年及2030年市場佔有率方法
  • 細分儀表板
  • 全球瘧疾診斷市場展望：依最終用途分類
  • 2018-2030年市場規模/預測與趨勢分析

第6章瘧疾診斷市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模、預測趨勢分析：
  • 非洲
    • 奈及利亞
    • 剛果民主共和國
    • 坦尚尼亞聯合共和國
    • 烏干達
    • 南非
    • 莫三比克
    • 安哥拉
    • 迦納
    • 波札那
    • 奈米比亞
  • 東南亞
    • 印度
    • 緬甸
    • 印尼
  • 東地中海
    • 沙烏地阿拉伯
    • 巴基斯坦
  • 西太平洋
    • 中國
    • 巴布亞紐幾內亞
    • 柬埔寨
  • 美洲
    • 委內瑞拉
    • 巴西
    • 哥倫比亞
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 土耳其

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Access Bio, Inc.
    • Abbott Laboratories
    • Premier Medical Corporation Pvt. Ltd.
    • Sysmex Partec GmbH
    • Siemens Healthineers
    • bioMerieux
    • Beckman Coulter, Inc.
    • Leica Microsystems GmbH
    • Bio-Rad Laboratories, Inc.
Product Code: 978-1-68038-711-7

Malaria Diagnostics Market Growth & Trends:

The global malaria diagnostics market size is projected to reach USD 900.5 million by 2030, expanding at a CAGR of 2.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights:

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis.
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count.
  • Africa led the market in 2023 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region.
  • Southeast Asia is expected to grow at a CAGR of 2.3% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
      • 3.2.1.2. Development of technologically advanced and efficient diagnostics
      • 3.2.1.3. Market players and private investors to curb the prevalence of malaria
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increasing number of countries in the malaria elimination phase
      • 3.2.2.2. Demand for low-cost malaria diagnostic tests
  • 3.3. Malaria Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Malaria Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Molecular Diagnostic Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Conventional PCR
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Modernized PCR
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Microscopy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Rapid Diagnostic Tests (RDT)

Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Method Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Malaria Diagnostics Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals & Clinics
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Academic and Research Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. Africa
    • 6.5.1. Nigeria
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Democratic Republic of the Congo
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. United Republic of Tanzania
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Uganda
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Africa
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Mozambique
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Angola
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Ghana
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Botswana
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Namibia
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. South East Asia
    • 6.6.1. India
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Myanmar
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Indonesia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Eastern Mediterranean
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Pakistan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Western Pacific
    • 6.8.1. China
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Papua New Guinea
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Cambodia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Americas
    • 6.9.1. Venezuela
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Brazil
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. Colombia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Europe
    • 6.10.1. UK
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Regulatory framework/ reimbursement structure
      • 6.10.1.3. Competitive scenario
      • 6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.2. Germany
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Regulatory framework/ reimbursement structure
      • 6.10.2.3. Competitive scenario
      • 6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.3. France
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Regulatory framework/ reimbursement structure
      • 6.10.3.3. Competitive scenario
      • 6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.4. Turkey
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Regulatory framework/ reimbursement structure
      • 6.10.4.3. Competitive scenario
      • 6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Access Bio, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Premier Medical Corporation Pvt. Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Sysmex Partec GmbH
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Siemens Healthineers
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. bioMerieux
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Beckman Coulter, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Leica Microsystems GmbH
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Bio-Rad Laboratories, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Africa malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Nigeria malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Nigeria malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Democratic Republic of Congo malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Democratic Republic of Congo malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Uganda malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Uganda malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 United Republic of Tanzania malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 United Republic of Tanzania malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 13 South Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 South Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mozambique malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Mozambique malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Angola malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Angola malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Ghana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Ghana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Botswana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Botswana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Namibia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Namibia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 South East Asia malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 26 South East Asia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 South East Asia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 India malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 29 India malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Myanmar malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Myanmar malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Indonesia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Indonesia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Eastern Mediterranean malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 35 Eastern Mediterranean malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Eastern Mediterranean malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Saudi Arabia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Saudi Arabia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Pakistan malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Pakistan malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Western Pacific malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 42 Western Pacific malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Western Pacific malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 China malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Papua New Guinea malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Papua New Guinea malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Cambodia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Cambodia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Americas malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 51 Americas malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Americas malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Venezuela malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Venezuela malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Brazil malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Brazil malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Colombia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Colombia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Europe malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 60 Europe malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Europe malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Turkey malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Turkey malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64 France malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 France malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 UK malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 67 UK malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Germany malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany malaria diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in Africa
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in South East Asia
  • Fig. 7 Primary interviews in Eastern Mediterranean
  • Fig. 8 Primary interviews in Western Pacific
  • Fig. 9 Primary interviews in Americas
  • Fig. 10 Primary interviews in Europe
  • Fig. 11 Market research approaches
  • Fig. 12 Value-chain-based sizing & forecasting
  • Fig. 13 QFD modeling for market share assessment
  • Fig. 14 Market formulation & validation
  • Fig. 15 Malaria Diagnostics market: market outlook
  • Fig. 16 Malaria Diagnostics competitive insights
  • Fig. 17 Parent market outlook
  • Fig. 18 Related/ancillary market outlook
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Industry value chain analysis
  • Fig. 21 Malaria Diagnostics market driver impact
  • Fig. 22 Malaria Diagnostics market restraint impact
  • Fig. 23 Malaria Diagnostics market strategic initiatives analysis
  • Fig. 24 Malaria Diagnostics market: Technology movement analysis
  • Fig. 25 Malaria Diagnostics market: Technology outlook and key takeaways
  • Fig. 26 Molecular Diagnostic Tests market estimates and forecasts, 2018 - 2030
  • Fig. 27 Conventional PCR market estimates and forecasts, 2018 - 2030
  • Fig. 28 Modernized PCR market estimates and forecasts, 2018 - 2030
  • Fig. 29 Microscopy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Rapid Diagnostic Tests (RDT) market estimates and forecasts, 2018 - 2030
  • Fig. 31 Malaria Diagnostics market: End Use movement analysis
  • Fig. 32 Malaria Diagnostics market: End Use outlook and key takeaways
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diagnostic Centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global malaria diagnostics market: Regional movement analysis
  • Fig. 37 Global malaria diagnostics market: Regional outlook and key takeaways
  • Fig. 38 Global malaria diagnostics market share and leading players
  • Fig. 39 Africa market share and leading players
  • Fig. 40 Europe market share and leading players
  • Fig. 41 South East Asia market share and leading players
  • Fig. 42 Eastern Mediterranean market share and leading players
  • Fig. 43 Western Pacific market share and leading players
  • Fig. 44 Americas market share and leading players
  • Fig. 45 Africa market estimates and forecasts, 2018 - 2030
  • Fig. 46 Nigeria market estimates and forecasts, 2018 - 2030
  • Fig. 47 Democratic Republic of Congo market estimates and forecasts, 2018 - 2030
  • Fig. 48 Uganda market estimates and forecasts, 2018 - 2030
  • Fig. 49 United Republic of Tanzania market estimates and forecasts, 2018 - 2030
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mozambique market estimates and forecasts, 2018 - 2030
  • Fig. 52 Angola market estimates and forecasts, 2018 - 2030
  • Fig. 53 Ghana market estimates and forecasts, 2018 - 2030
  • Fig. 54 Botswana market estimates and forecasts, 2018 - 2030
  • Fig. 55 Namibia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Turkey market estimates and forecasts, 2018 - 2030
  • Fig. 61 South East Asia market estimates and forecasts, 2018 - 2030
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Myanmar market estimates and forecasts, 2018 - 2030
  • Fig. 64 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 65 Eastern Mediterranean market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 Pakistan market estimates and forecasts, 2018 - 2030
  • Fig. 68 Western Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Papua New Guinea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Cambodia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Americas market estimates and forecasts, 2018 - 2030
  • Fig. 73 Venezuela market estimates and forecasts, 2018 - 2030
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Malaria Diagnostics market